SFX by Ex Libris Inc.

Title:	Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition
Source:	Nature Medicine [1078-8956] Vaccari, Monica yr:2016

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Parra, Gabriel I. "Static and Evolving Norovirus Genotypes: Implications for Epidemiology and Immunity." PLoS Pathogens 13.1 (2017).
description	2.	Gordon, Shari N. "Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition." The journal of immunology 197.7 (2016): 2726-2737.
description	3.	Fenizia, C. "TRIM5 Does Not Affect Simian Immunodeficiency Virus SIVmac251 Replication in Vaccinated or Unvaccinated Indian Rhesus Macaques following Intrarectal Challenge Exposure." Journal of virology 85.23 (2011): 12399-12409.
description	4.	Nelson, Cody S. "Combined HIV-1 Envelope Systemic and Mucosal Immunization of Lactating Rhesus Monkeys Induces a Robust Immunoglobulin A Isotype B Cell Response in Breast Milk." Journal of virology 90.10 (2016): 4951-4965.
description	5.	Boesch, Austin W. "The role of Fc receptors in HIV prevention and therapy." Immunological reviews 268.1 (2015): 296-310.
description	6.	Thery, L. "Emergence of new recombinant noroviruses GII.p16-GII.4 and GII.p16-GII.2, France, winter 2016 to 2017." Euro surveillance : bulletin européen sur les maladies transmissibles = European communicable disease bulletin. 22.15.
description	7.	Ferrari, G. "Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection." Nature reviews. Drug discovery 15.12 (2016): 823-834.
description	8.	Dowd, S.-Y. A. "Rapid development of a DNA vaccine for Zika virus." Science 354.6309 (2016): 237-240.
description	9.	Bournazos, S. "Fcγ receptor pathways during active and passive immunization." Immunological reviews 268.1 (2015): 88-103.
description	10.	Brown, Eric P. "High-throughput, multiplexed IgG subclassing of antigen-specific antibodies from clinical samples." Journal of immunological methods 386.1-2 (2012): 117-123.
description	11.	Larocca, Rafael A. "Vaccine protection against Zika virus from Brazil." Nature 536.7617 (2016): 474-478.
description	12.	Lok, S. "Structure of the thermally stable Zika virus." Nature 533.7603 (2016): 425-428.
description	13.	Granato, C. "New threat on the horizon: The Zika virus." International journal of gynecology and obstetrics 133.2 (2016): 137-138.
description	14.	Shan, C. "Zika Virus: Diagnosis, Therapeutics, and Vaccine." ACS infectious diseases 2.3 (2016): 170-172.
description	15.	Barouch, Dan H H. "Protective efficacy of adenovirus-protein vaccines against SIV challenges in rhesus monkeys." Science 349.6245 (2015): 320-324.
description	16.	"Herd immunity: hyperimmune globulins for the 21st century." Lancet Infectious Diseases 18.4: 361-363.
description	17.	Huang, Z. "Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS." Gene Therapy 24.7 (2017): 377-384.
description	18.	Reynolds, Steven J. "Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda." AIDS research and human retroviruses (2016).
description	19.	Nawaz, F. "Hiv-1 gp120: A target for therapeutics and vaccine design." Current drug targets 17.1 (2016): 122-135.
description	20.	Asbach, B. "Potential To Streamline Heterologous DNA Prime and NYVAC/Protein Boost HIV Vaccine Regimens in Rhesus Macaques by Employing Improved Antigens." Journal of virology 90.8 (2016): 4133-4149.